We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Saturday
May 07
08:45 - 10:00
Auditorium 11
Soft tissue sarcoma: Brachytherapy and/or EBRT or IORT - Current evidence
Csaba Polgar, Hungary;
Vratislav Strnad, Germany
In this session prestigious speakers will discuss and define current evidence for the optimal local radio-oncological treatment strategy with or without surgery for soft tissue sarcoma - the current evidence for EBRT, brachytherapy and IORT alone or for IORT /brachytherapy as a boost in adult soft-tissue sarcomas of the extremity, trunk and retroperitoneal space. For all treatment approaches the technical and practical state of the art considerations and recommendations will be also presented.
Debate
Brachytherapy
09:27 - 09:47
Value of IORT
Falk Röder, Austria
SP-0032

Abstract

Value of IORT
Authors:

Falk Roeder1

1University of Salzburg, Radiation Oncology, Salzburg, Austria

Show Affiliations
Abstract Text

In this talk, we will summarize the current evidence for IORT as a boost strategy preceeded or followed by EBRT in adult soft-tissue sarcomas of the extremity, trunk and retroperitoneal space and discuss the pros and cons of IORT in certain clinical situations. We will further present technical and practical considerations for state of the art performance of IORT based on the recently pupblished ESTRO-ACROP guideline for IORT in soft-tissue sarcoma, as well as further directions of IORT for example image-guided IORT.